Obsessive-compulsive disorder: A 3-year prospective follow-up study of patients treated with serotonin reuptake inhibitors. OCD follow-up study

Journal of Psychiatric Research

Volumn 40, Issue 6, 2006, Pages 502-510

  Catapano, Francesco ^a   Perris, Francesco ^a   Masella, Mariangela ^a   Rossano, Flavia ^a   Cigliano, Marco ^a   Magliano, Lorenza ^a   Maj, Mario ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Follow up; Obsessive compulsive disorder; Outcome; Serotonin reuptake inhibitors

Indexed keywords

CITALOPRAM; CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; NEUROLEPTIC AGENT; PAROXETINE; PIMOZIDE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HAMILTON SCALE; HUMAN; INFORMATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OBSESSIVE COMPULSIVE DISORDER; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; RECURRENT DISEASE; REMISSION; SCHIZOTYPAL PERSONALITY DISORDER; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 33746796757     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2005.04.010     Document Type: Article

References (58)

1. Abramowitz J.S. Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review. Journal of Consulting and Clinical Psychology 65 (1997) 44-52
2. Ackerman D.L., Greenland S., Bystritsky A., Morgenstern H., and Katz R.J. Predictors of treatment response in obsessive-compulsive disorder: multivariate analyses from a multicenter trial of clomipramine. Journal of Clinical Psychopharmacology 14 (1994) 247-254
3. Akhtar S., Wig N.N., Varma V.K., Pershad D., and Verma S.K. A phenomenological analysis of symptoms in obsessive-compulsive neurosis. British Journal of Psychiatry 127 (1975) 342-348
4. Alarcon R.D., Libb J.W., and Spitler D. A predictive study of obsessive-compulsive disorder response to clomipramine. Journal of Clinical Psychopharmacology 13 (1993) 210-213
5. Alonso P., Menchon J.M., Pifarre J., Mataix-Cols D., Torres L., Salgado P., et al. Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioural therapy. Journal of Clinical Psychiatry 62 (2001) 535-540
6. Baer L., and Minichiello W.E. Behavior therapy of obsessive-compulsive disorder. In: Jenike M.A., Baer L., and Minichiello W.E. (Eds). Obsessive-compulsive disorders: theory and managment. 2nd ed (1990), Medical Publishers, Chicago 203-232
7. Baer L., Jenike M.A., Black D.W., Treece C., Rosenfeld R., and Greist J. Effect of axis II diagnoses on treatment outcome with clomipramine in 55 patients with obsessive-compulsive disorder. Archives of General Psychiatry 49 (1992) 862-866
8. Basoglu M., Lax T., Kasvikis Y., and Marks I.M. Predictors of improvement in obsessive-compulsive disorder. Journal of Anxiety Disorder 2 (1988) 299-317
9. Bebbington P.E. Epidemiology of obsessive-compulsive disorder. British Journal of Psychiatry 35 (1998) 2-6
10. Black D.W., Monahan P., Gable J., Blum N., Clancy G., and Baker P. Hoarding and treatment response in 38 non depressed subjects with obsessive-compulsive disorder. Journal of Clinical Psychiatry 59 (1998) 420-425
11. Buchanan A.W., Meng K.S., and Marks I.M. What predicts improvement and compliance during the behavioral treatment of obsessive-compulsive disorder?. Anxiety 2 (1996) 22-27
12. Castle D.J., Deale A., Marks I.M., Cutts F., Chadhoury Y., and Stewart A. Obsessive-compulsive disorder: prediction of outcome from behavioural psychotherapy. Acta Psychiatrica Scandinavica 89 (1994) 393-398
13. Cottraux J., Messy P., Marks I.M., Mollard E., and Bouvard M. Predictive factors in the treatment of obsessive-compulsive disorders with fluvoxamine and/or behaviour therapy. Behavioural Psychotherapy 21 (1993) 45-50
14. de Haan E., van Oppen P., van Balkom A.J.L.M., Spinhoven P., Hoogduin K.A.L., and Van Dyck R. Prediction of outcome and early vs. late improvement in OCD patients treated with cognitive behaviour therapy and pharmacotherapy. Acta Psychiatrica Scandinavica 96 (1997) 354-361
15. Degonda M., Wyss M., and Angst J. The Zurich Study. XVIII. Obsessive-compulsive disorders and syndromes in the general population. European Archives of Psychiatry and Clinical Neuroscience 243 (1993) 16-22
16. Demal U., Lenz G., Mayrhofer A., Zapotoczky H.G., and Zitterl W. Obsessive-compulsive disorder and depression: a retrospective study on course and interaction. Psychopathology 26 (1993) 145-150
17. Dreessen L., Hoekstra R., and Arntz A. Personality disorders do not influence the results of cognitive and behavior therapy for obsessive-compulsive disorder. Journal of Anxiety Disorder 11 (1997) 503-521
18. Drummond L.M. The treatment of severe, chronic, resistant obsessive-compulsive disorder. An evaluation of an in-patient programme using behavioral psychotherapy in combination with other treatments. British Journal of Psychiatry 163 (1993) 223-229
19. Eisen J.L., and Steketee G. Course of illness in obsessive-compulsive disorder. In: Pato M.T., and Steketee G. (Eds). OCD across the life cycle (1997), American Psychiatric Press, Arlington 73-95
20. Eisen J.L., Goodman W.K., Keller M.B., Warshaw M.G., DeMarco L.M., Luce D.D., et al. Patterns of remission and relapse: in obsessive-compulsive disorder: a 2-year prospective study. Journal of Clinical Psychiatry 60 (1999) 346-351
21. Endicott J., Andreasen N.C., and Spitzer R.L. Family history research diagnostic criteria (1975), New York State Psychiatric Institute Biometrics Research, New York
22. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured clinical interview for DSM-IV Axis I disorders (SCID-I), clinician version (1997), American Psychiatric Press, Washington
23. Foa E.B., and Franklin M.E. Psychotherapies for obsessive-compulsive disorder: a review. In: Maj M., Sartorius N., Okasha A., and Zohar J. (Eds). Obsessive-compulsive disorder. 2nd ed (2002), Wiley, Chichester 93-115
24. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill C.L., et al. The Yale-Brown obsessive compulsive scale. I. Development, use, and reliability. Archives of General Psychiatry 46 (1989) 1006-1011
25. Goodman W.K., McDougle C.J., Barr L.C., Aronson S.C., and Price L.H. Biological approaches to treatment-resistant obsessive compulsive disorder. Journal of Clinical Psychiatry 54 Suppl (1993) 16-26
26. Goodman W.K., Ward H., Kablinger A., and Murphy T. Fluvoxamine in the treatment of obsessive-compulsive disorder and related condition. Journal of Clinical Psychiatry 58 Suppl (1997) 32-49
27. Goodwin D.W., Guze S.B., and Robins E. Follow-up studies in obsessional neurosis. Archives of General Psychiatry 20 (1969) 182-187
28. Greist J.H., and Jefferson J.W. Pharmacotherapy for obsessive-compulsive disorder. British Journal of Psychiatry 35 Suppl (1998) 64-70
29. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23 (1960) 56-62
30. Hollander E., Kwon J.H., Stein D.J., Broatch J., Rowland C.T., and Himelein C.A. Obsessive-compulsive and spectrum disorders: overview and quality of life issues. Journal of Clinical Psychiatry 8 (1996) 3-6
31. Hollander E., Baldini Rossi N., Sood E., and Pallanti S. Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo controlled study. International Journal of Neuropsychopharmacology 6 (2003) 397-401
32. Ingram I.M. Obsessional illness in mental hospital patients. Journal of Mental Science 107 (1961) 382-402
33. Jenike M.A., Baer L., Minichiello W.E., Schwartz C.E., and Carey R.J. Concomitant obsessive-compulsive disorder and schizotypal personality disorder. American Journal of Psychiatry 143 (1986) 530-532
34. Kaplan A., and Hollander E. A review of pharmacologic treatments for obsessive-compulsive disorder. Psychiatric Services 54 (2003) 1111-1118
35. Kobak K.A., Greist J.H., Jefferson J.W., Katzelnick D.J., and Henk H.J. Behavioral versus pharmacological treatments of obsessive-compulsive disorder: a meta-analysis. Psychopharmacology 136 (1998) 205-216
36. Kringlen E. Obsessional neurotics: a long-term follow-up. British Journal of Psychiatry 111 (1965) 709-722
37. Leonard H.L., Swedo S.E., Lenane M.C., Rettew D., Cheslow D.L., Hamburger S.D., et al. A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescent with obsessive-compulsive disorder. Archives of General Psychiatry 48 (1991) 922-927
38. Leonard H.L., Swedo S.E., Lenane M.C., Rettew D., Hamburger S.D., Bartko J.J., et al. A 2- to 7-year follow-up study of 54 obsessive-compulsive children and adolescents. Archives of General Psychiatry 50 (1993) 429-439
39. March J., Frances A., Kahn D., and Carpenter D. Expert consensus guidelines: treatment of obsessive-compulsive disorder. Journal of Clinical Psychiatry 4 (1997) 1-72
40. Mataix-Cols D., Rauch S.L., Manzo P.A., Jenike M.A., and Baer L. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. American Journal of Psychiatry 156 (1999) 1409-1416
41. McDougle C.J., Goodman W.K., Leckman J.F., Lee N.C., Heninger G.R., and Price L.H. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. a double-blind, placebo-controlled study in patients with and without tics. Archives of General Psychiatry 51 (1994) 302-308
42. McDougle C.J., Epperson C.N., Pelton G.H., Wasylink S., and Lawrence H.P. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Archives of General Psychiatry 57 (2000) 794-801
43. Minichiello W.E., Bear L., and Jenike M.A. Schizotypal personality disorder: a poor prognostic indicator for behaviour therapy in the treatment of obsessive-compulsive disorder. Journal of Anxiety Disorder 1 (1987) 273-276
44. Orloff L.M., Battle M.A., Baer L., Ivanjack L., Pettit A.R., Buttolph L., and Jenike M.A. Long-term follow-up of 85 patients with obsessive-compulsive disorder. American Journal of Psychiatry 151 (1994) 441-442
45. Pato M.T., Zohar-Kadouch R., Zohar J., and Murphy D.L. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder. American Journal of Psychiatry 145 (1988) 1521-1525
46. Pigott T.A., Pato M.T., Bernstein S.E., Grover G.N., Hill J.L., Tolliver T.J., and Murphy D.L. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Archives of General Psychiatry 47 (1990) 1543-1550
47. Pigott T.A., and Seay S. Pharmacotherapy of obsessive-compulsive disorder. International Review of Psychiatry 9 (1997) 133-147
48. Pollitt J. Natural history of obsessional states; a study of 150 cases. British Medical Journal 32 (1957) 194-198
49. Rasmussen S.A., and Tsuang M.F. Clinical characteristics and family history in DSM-III obsessive-compulsive disorder. American Journal of Psychiatry 143 (1986) 317-322
50. Rasmussen S.A., and Eisen J.L. The epidemiology and clinical features of obsessive compulsive disorder. In: Jenike M.A., Baer L., and Minichiello W.E. (Eds). Obsessive-compulsive disorders: theory and managment. 2nd ed (1990), Medical Publishers, Chicago 10-27
51. Ravizza L., Barzega G., Bellino S., Bogetto F., and Maina G. Predictors of drug treatment response in obsessive-compulsive disorder. Journal of Clinical Psychiatry 56 (1995) 368-373
52. Skoog G., and Skoog I. A 40-year follow-up of patients with obsessive-compulsive disorder. Archives of General Psychiatry 56 (1999) 121-132
53. Spitzer R.L., Williams J.B.W., Gibbon M., and First M.B. The structured clinical interview for DSM-III-R Axis II disorders (SCID-II) (1990), American Psychiatric Press, Washington
54. Steketee G., and Shapiro L. Predicting behavioral treatment outcome for agoraphobia and obsessive-compulsive disorder. Clinical Psychology Review 15 (1995) 317-346
55. Steketee G., Eisen J.L., Ingrid D., Meredith W., and Rasmussen S. Predictors of course in obsessive-compulsive disorder. Psychiatry Research 89 (1999) 229-238
56. Tamimi R.R., and Mavissakalian M.R. Are effective antiobsessional drugs interchangeable [letter]?. Archives of General Psychiatry 48 (1991) 857-878
57. van Balkom A.J.L.M., van Oppen P., Vermeulen A.W., Nauta M.C.E., Vorst H.C.M., and Van Dyck R. A meta-analysis on the treatment of obsessive-compulsive disorder: a comparison of antidepressants, behavior therapy and cognitive therapy. Clinical Psychology Review 14 (1994) 359-381
58. Zohar J., Sasson Y., Chopra M., Amital D., and Iancu I. Pharmacological treatment of obsessive-compulsive disorder: a review. In: Maj M., Sartorius N., Okasha A., and Zohar J. (Eds). Obsessive-compulsive disorder. 2nd ed (2002), Wiley, Chichester 43-61